Skip to main content
See the bias in every story
Published • loading... • Updated

Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock: Insider Renee Gala Sells 2,000 Shares

Summary by MarketBeat
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ - Get Free Report) CEO Renee Gala sold 2,000 shares of the firm's stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $236.40, for a total transaction of $472,800.00. Following the completion of the transaction, the chief executive officer directly owned 141,394 shares in the company, valued at approximately $33,425,541.60. This represents a 1.39% decrease in their …

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Wednesday, October 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal